Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K
Date of Report: May 1, 2026
Event: Submission of matters to a vote of security holders at the annual meeting of stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document reports on corporate governance votes rather than financial performance.
Material Changes
No material financial changes are reported in this filing. The document details the outcomes of shareholder votes regarding board composition, auditor ratification, and executive compensation.
Outlook, Management Commentary, and Risks
Management Commentary: The Company stated it will continue to include annual advisory stockholder votes on executive compensation in its proxy materials until at least the next required advisory vote on frequency.
Voting Results:
- Director Election (Ernst G. Hoyer): Approved (1,330,333 For; 1,070,640 Withheld).
- Director Election (James H. Beeson): Approved (1,708,941 For; 692,032 Withheld).
- Auditor Ratification (Haynie & Co.): Approved (2,753,278 For; 16,273 Against).
- Executive Compensation (Say-on-Pay): Approved (2,354,919 For; 38,451 Against).
Investor Verification Checklist
- Verify the total number of shares outstanding to contextualize the voting percentages.
- Review the full proxy statement for details on the compensation packages approved by shareholders.
- Confirm the tenure and background of the newly elected directors, Ernst G. Hoyer and James H. Beeson.
- Check subsequent filings for the company's financial results for the period ended December 31, 2026, as the auditor was ratified for this period.